News

“Feasibility of Wave Health to monitor electronic patient-reported outcomes (ePROs) in prostate cancer patients” presents further findings

Highlights
Background
Benefits of electronic patient-reported outcomes (ePROs) are well established, but concerns exist around their applicability in certain cancer patient populations. This multicenter study aimed to evaluate the feasibility and compliance of a novel platform, Wave Health, […]

Barcelona, Spain and El Segundo, California – Nov 18
ACCEPTED ABSTRACTS INCLUDE:
Spain PRO-WAVE1 study, conducted with eight hospitals, “PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform” (presents on November 18)
UK feasibility study, conducted with Health Innovation Oxford & Thames Valley, “Enhancing Prostate Cancer Management […]

Lisbon, Portugal and El Segundo, CA – November 11
“PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform” presents further findings on November 9, 2024.
Lisbon, Portugal and El Segundo, CA – Joining top experts across various cancer fields, including oncology, radiology and urology, Wave Health has […]

Yokohama, Japan and El Segundo, California – Treatment Technologies & Insights (TTI), a digital health insights and real-world data company and developer of the #1 rated ePRO app for Oncology, Wave Health, announced today it has been named a 2024 ASCO Breakthrough Abstract Award winner in recognition of their 8-clinic PRO-WAVE1 study conducted in Spain. […]

Washington, D.C. – Interim results of a joint feasibility study conducted by TTI and the Wilmot Cancer Institute were selected for oral abstract presentation at the 2024 Oncology Nursing Society (ONS) Congress in Washington D.C.

San Francisco, CA – Treatment Technologies & Insights (TTI), a digital health insights and real-world data company that developed the Wave Health platform, including the #1 ranked ePRO app1, today announced significant results of an eight-hospital, three-month study in Spain focused on prostate cancer patients (mHSPC, mCRPC, nmPC) undergoing systemic therapy.
In the PRO-WAVE1 […]

By Matt Lashey, MBA, & Alex Whitehead, BS — Originally posted in NCODA’s Inspire Magazine (Spring 2023) — It takes a village to overcome cancer. While oncology patients have always relied on networks of caregivers, oncologists, nurses, pharmacists, and the manufacturers of their medications, how these groups work together to improve outcomes is becoming increasingly […]

— Treatment Technologies & Insights’ (TTI) ePRO app solution, Wave Health, enabled innovative approach to capture real-world symptoms and side effects —
SEATTLE, WA and EL SEGUNDO, CA, May 31, 2023 – The Wave Health digital health platform, used to collect patient symptom and quality of life information in an innovative research study, comprises two […]

Editor’s Note: CoverMyMeds is publishing recaps of Monday, Tuesday and Wednesday Asembia 2022 sessions. Over 6,000 attendees are gathered this week in Las Vegas for Asembia 2022, a specialty pharmacy summit. We attended Wednesday’s sessions, which were focused on incoming tools and trends specialty pharmacists can use to help patients get the medications they need — […]

May 4, 2022 Aislinn Antrim, Associate Editor – Pharmacy Times
Pharmacists can play a more active role in educating patients on tools and resources available to them, enrolling patients in programs, gathering subjective and objective data. Pharmacists are increasingly playing an active role in the collection of patient-reported outcomes and the use of real-world evidence, […]